Contract Archives - Mediarabe

Nurses at Backus Hospital in Norwich plan to strike Tuesday in protest over contract talks

October 12, 2020

Nurses at Backus Hospital in Norwich are set to strike Tuesday and Wednesday to protest what they say is the company’s refusal to negotiate a contract.

The hospital and Backus Federation of Nurses, part of AFT Connecticut that represents more than 400 nurses have been in contract talks since June. The two sides differ on compensation, improved distribution of personal protective equipment and recruiting and keeping new nurses, according to the union.

A spokeswoman for parent company Hartford HealthCare did not immediately respond to questions about staffing at Backus Hospital during the walkout. Donna Handley, president of the hospital, said earlier this month Backus will remain open during a strike and will work to reach an agreement.

Union President Sherri Dayton said recent negotiations led to progress on improved protective gear policies, expanded access for breastfeeding by new mothers and accountability for safe patient limits.

But the company has not

Regeneron CEO says U.S. secured 300k doses of antibody cocktail with $450 million contract

October 11, 2020

| No Comments

| Health News

Washington — Dr. Leonard Schleifer, the founder and CEO of Regeneron Pharmaceuticals, which developed the antibody cocktail heralded by President Trump, estimated Sunday that a $450 million contract the company won from the federal government over the summer will secure roughly 300,000 doses of the treatment.

“They bought from us several hundred thousand, maybe around 300,000 doses, which they are going to make it for free,” Schleifer said in an interview with “Face the Nation.” “We can’t do this alone. We need the entire industry.”

The Trump administration announced in July it signed a $450 million contract with Regeneron to supply the treatment. But with the number of new coronavirus cases outpacing the doses of the drug available, Schleifer conceded the federal government, together with ethics experts at the Food and Drug Administration, will have to decide who receives the limited supply.

“Coming up with a distribution system where we

BioHiTech Global Receives Contract to Install Seven New Food Waste Digesters at Various Hackensack Meridian Health Locations

October 10, 2020

| No Comments

| Health Food

CHESTNUT RIDGE, N.Y., Oct. 6, 2020 /PRNewswire/ — BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a sustainable technology and services company, announced today that the Company has received a lease contract to install seven new food waste digesters at various Hackensack Meridian Health locations.

BioHiTech expects to complete the installations of the seven Revolution Series™ digesters in the fourth quarter of 2020. The orders were received through the Company’s distribution partnership with a leading national provider of environmental and regulated waste management solutions. The new food waste digesters will help Hackensack Meridian Health reduce the environmental impact of its operations by safely disposing of food waste on-site, thereby lowering the amount of greenhouse gases emitted from traditional disposal methods. The Company’s data analytics platform will also provide real-time transparency for food waste generation to help Hackensack Meridian Health in its waste reduction efforts.

“Healthcare represents a substantial

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

October 8, 2020

| No Comments

| Health Article

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

PR Newswire

WASHINGTON, Oct. 8, 2020

WASHINGTON, Oct. 8, 2020 /PRNewswire/ — Today, the Berkeley Research Group (BRG) published an analysis of historical trends in 340B contract pharmacy arrangements. The findings conclude that the growth in the number of these arrangements is fueling explosive growth in the program at large and driving the 340B program farther and farther away from its original intended goal of providing discounted medicines to safety-net entities treating uninsured and vulnerable patients.

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

Congress created the 340B program to help safety-net providers, including certain qualifying hospitals and federally-funded clinics, access discounts on prescription medicines for low-income or uninsured patients. In 2010, a Health Resources and Services Administration (HRSA) policy opened the door to allow

S.F.-Marin Food Bank ratifies union contract after yearlong battle where workers alleged institutional racism

October 7, 2020

| No Comments

| Health Food

The San Francisco-Marin Food Bank, one of the Bay Area’s most prominent hunger relief nonprofits, was thrust into the spotlight this year, as long lines formed at food pantries and the need for food swelled. But behind the scenes, there’s been a yearlong battle going on after workers voted to unionize — something they finalized just recently. After simmering discontent about institutional racism and lack of worker protections, the food bank and its staff have agreed on a new contract.

With Office and Professional Employees International Union Local 29, employees now have more job protections, guaranteed raises and better benefits, which they hope will make the food bank feel like a more equitable place to work as they continue to feed 60,000 households weekly.

“After the firemen, police and other first responders during a crisis, food bankers come in and make sure the community is being fed,” said Abel Murillo,

Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19)

October 6, 2020

| No Comments

| Health Facts

$18.2 million in Phase 2 funding will support the development and scale-up of COVID-19 antigen test based on Simoa^® technology

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has entered into a Phase 2 contract with the National Institutes of Health (NIH) through its Rapid Acceleration of Diagnostics (RADx℠) initiative. The contract, which has a total award value of $18.2 million, will accelerate the continued development, scale-up and deployment of a novel SARS-CoV-2 antigen test based on Quanterix’ ultra-sensitive Simoa technology. Preliminary results indicate that the test has the potential to enable detection from a variety of sample types including self-collected capillary blood, saliva and nasal swabs.

“The need for accurate and reliable testing in response to the global COVID-19 pandemic continues, and we are honored to have been selected by the NIH to progress to Phase

New Zealand’s Ubiquitome signs NIH RADx contract

October 6, 2020

| No Comments

| Health Article

Its Liberty16 open system RT-PCR offers rapid, mobile testing for COVID

New Zealand-based Ubiquitome is ramping up production of its mobile, real-time (RT) PCR technology with funding from the United States’ National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative.

Ubiquitome is the only NZ private company to be accepted into the highly competitive RADx and to receive federal funding through the NIH in recent years.

As one of the first RADx-Tech contracts awarded outside the US, Ubiquitome will scale its Liberty16 mobile PCR technology to enable thousands of tests per day by the end of the year.

The Liberty16 will be targeted for use by rural and metropolitan hospitals and mobile labs to test for SARS-CoV-2 – the virus that causes COVID-19.

Ubiquitome’s device can detect virus in 16 samples in 40 minutes or less. It reports positive or negative results via its proprietary iPhone app.

Battery-operated,

Accresa Wins Breach of Contract Verdict Against Hint Health

October 6, 2020

| No Comments

| Health Benefits

Accresa has secured a verdict in federal court against Hint Health, affirming its breach of contract claim

DALLAS–(BUSINESS WIRE)–October 6, 2020–

Accresa, a technology provider focused on healthcare payments solutions for employers and provider networks, has won a verdict in federal court against San Francisco-based software company Hint Health.

The verdict was announced on September 30, 2020, following a two-week jury trial before Judge Amos L. Mazzant, III in the U.S. District Court for the Eastern District of Texas in Sherman (4:18-cv-00536-ALM-CMC). Jurors found in favor of Accresa for its breach of contract claim, and rejected the entirety of Hint Health’s counterclaims against Accresa.

“As we maintained throughout the trial, Accresa worked in good faith to uphold its obligations under the partnership agreement with Hint Health, whereas Hint did not,” said Accresa CEO William Short. “We are proud of the work our team has done in partnership with national health

BioHiTech Global Receives Contract to Install Seven New Food Waste Digesters at Various Hackensack Meridian Health Locations | News

October 6, 2020

| No Comments

| Health Food

CHESTNUT RIDGE, N.Y., Oct. 6, 2020 /PRNewswire/ — BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a sustainable technology and services company, announced today that the Company has received a lease contract to install seven new food waste digesters at various Hackensack Meridian Health locations.

BioHiTech expects to complete the installations of the seven Revolution Series™ digesters in the fourth quarter of 2020. The orders were received through the Company’s distribution partnership with a leading national provider of environmental and regulated waste management solutions. The new food waste digesters will help Hackensack Meridian Health reduce the environmental impact of its operations by safely disposing of food waste on-site, thereby lowering the amount of greenhouse gases emitted from traditional disposal methods. The Company’s data analytics platform will also provide real-time transparency for food waste generation to help Hackensack Meridian Health in its waste reduction efforts.

“Healthcare represents a substantial

Contract Tracing, Key to Reining in the Virus, Falls Flat in the West

October 3, 2020

| No Comments

| Health News

LONDON — As the coronavirus stampeded across Europe and the United States this spring, governments made their depleted citizens a tantalizing promise: Soon, legions of disease detectives would hunt down anyone exposed to the virus, confining them to their homes and letting everyone else get on with their lives.

Nearly eight months on, as a web of new infections spreads across Europe and the United States, that promise has nearly evaporated.

Despite repeated vows by Western nations to develop “world-beating” testing and tracing operations, those systems have been undone by a failure of governments to support citizens through onerous quarantines or to draw out intimate details of their whereabouts. That has shattered the hope of pinpoint measures replacing lockdowns and undermined flagging confidence in governments.

Beholden to privacy rules, Western officials largely trusted people to hand over names to contact tracers. But that trust was not repaid, in large part

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30